While defects in MMR proteins lead to TMZ resistance and tumorigenesis, MMR deficiency has also been associated with better response to ICBs at least in NSCLC (207) and colorectal carcinoma (208). The gene discussed is MRC1; the disease is colorectal carcinoma.